Tang Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,826,692
| Closed | -$38.2M | – | 203 |
|
|
2025
Q2 | $38.2M | Buy |
3,826,692
+1,137,492
| +42% | +$9.16M | 1.93% | 12 |
|
|
2025
Q1 | $16.1M | Buy |
2,689,200
+2,467,484
| +1,113% | +$18.1M | 0.89% | 30 |
|
|
2024
Q4 | $1.7M | Sell |
221,716
-2,186,084
| -91% | -$18.8M | 0.11% | 108 |
|
|
2024
Q3 | $24.6M | Buy |
+2,407,800
| New | +$36.7M | 1.76% | 14 |
|
|
2023
Q2 | – | Sell |
-216,700
| Closed | -$2.95M | – | 105 |
|
|
2023
Q1 | $2.95M | Hold |
216,700
| – | – | 0.44% | 54 |
|
|
2022
Q4 | $4.23M | Sell |
216,700
-720,800
| -77% | -$14.1M | 0.61% | 41 |
|
|
2022
Q3 | $17.9M | Hold |
937,500
| – | – | 2.19% | 15 |
|
|
2022
Q2 | $19.3M | Hold |
937,500
| – | – | 2.93% | 10 |
|
|
2022
Q1 | $30.2M | Hold |
937,500
| – | – | 6.11% | 4 |
|
|
2021
Q4 | $43.6M | Buy |
937,500
+37,500
| +4% | +$1.25M | 8.78% | 5 |
|
|
2021
Q3 | $24.3M | Buy |
900,000
+680,604
| +310% | +$17.8M | 5.05% | 7 |
|
|
2021
Q2 | $5.63M | Buy |
+219,396
| New | +$5.23M | 1.12% | 12 |
|